Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Chongqing Huapont Pharma plans to raise $146 million in a...
China Kanghui Holdings will be acquired by fellow medical...
A major, though as-yet unnamed, China biopharma has...
A major, though still unnamed, China biopharma bought a...
Joinn Laboratories, a China pre-clinical CRO, is the...
Regeneron Pharmaceuticals and Bayer...
Reckitt Benckiser, a British maker of OTC drugs, acquired...
China’s pharmaceutical market will continue to grow...
Bayer HealthCare and Peking University...
Eddingpharm, a China drug in-licensing company, acquired...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
